New research shows that marijuana compounds fight cancer!
LONDON, England (PNN) - October 22, 2013 - Debate is just beginning in Washington over how medical marijuana will be grown and distributed now that the rules for the recreational market are established. Meanwhile, research into medical benefits of compounds within the cannabis plant continues to show effectiveness.
Effectiveness against pain in its many forms and other side effects of major diseases - or the palliative side of marijuana use - have been pretty well established, but can marijuana directly take on a disease as big, scary and deadly as cancer?
“What we’ve shown using just a few of these (cannabis) compounds is that the effects against cancer are profound. They really are,” said Dr. Wai Liu, a senior research fellow at St George’s University of London.
Liu’s most recent published research “explored the activity of six cannabinoids, used both alone and in combination in leukemic cells.” The research was published in Anticancer Research: International Journal of Cancer Research and Treatment.
He said the anticancer activity of THC has been “known for sometime” but that THC’s psychoactive effect or tendency to get you high limits its use as a cancer-fighting agent. That’s partly due to the negative social stigma about getting high and, of course, not everyone wants to experience a high.
So he set out to explore the cancer fighting ability of other cannabinoids that don’t get you high.
“We have shown that these six other agents that lack psychoactivity are just as effective as an anti-cancer agent,” he said. Chief among the six was cannabidiol or CBD.
His research found that “if you were to use one or two of these on their own, that would inhibit cancer growth. However, we’re clinicians. Not only do we want cancer to not grow, but we’re also wanting to see cell death.”
He said his study showed that once these cells are taken out of the treatment solution causing them to stop growing, the cells die from the toxic effects of the treatment. Liu believes his results are strong enough that he hopes to start clinical trials involving humans in 12 to 18 months.
“We’ve clearly shown in the lab that these drugs work,” he said.
